From Refugee to Antiviral Pioneer: The Road Behind Raymond Schinazi's HIV and Hepatitis Work
Biotech·November 9, 2026
Few researchers in antiviral medicine can trace their career back to a childhood that began in Egypt, passed through refugee life in Italy and ended at a British boarding school. Raymond Schinazi's route was exactly that unusual. In an episode of The Life Scientific, the BBC Radio 4 series presented by Jim al-Khalili, he looked back on how that winding path shaped his work.
His interest in medicine started early, sparked by his mother's brush with a potentially deadly illness during his childhood. The family was then forced out of their homeland and arrived in Italy as refugees. A scholarship to a boarding school in Britain gave him a more stable footing, and from there he moved into chemistry and biology and built a career in the laboratory.
Schinazi now directs the Laboratory of Biochemical Pharmacology at Emory University in Atlanta. He also set up the university's Center for AIDS Research. His early work on HIV helped lead to drugs that many people living with the virus still take today. His contribution to the effort to develop a cure for hepatitis C has also saved millions of lives around the world.
Those achievements sit within a broader shift in medicine. Viruses that were once close to a death sentence are now treatable in many cases, and drugs for HIV, hepatitis and herpes show how far that change has gone. In the interview, Schinazi reflects on his route to success and explains why he is confident that more big breakthroughs are still to come.
Reporting based on an external source.